Institution · Western Sky Medical Research

Most cited papers from Western Sky Medical Research

Western Sky Medical Research

What are the most cited papers from Western Sky Medical Research?

The most cited paper from Western Sky Medical Research is "A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma" (Jonathan Corren, William W. Busse, Eli O. Meltzer et al., 2010), with 299 citations. Next come "Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial" (125) and "Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide" (106).

Published TypeFieldAccessCitations

Showing 32 of 32 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma Jonathan Corren, William W. Busse, Eli O. Meltzer et al. · American Journal of Respiratory and Critical Care Medicine	7 Jan 2010	299
2	Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial Gary T. Ferguson et al. · The Lancet Respiratory Medicine	22 May 2017	125
3	Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide Lyndon E. Mansfield, Gonzalo Díaz, Catherine R. Posey et al. · Annals of Allergy Asthma & Immunology	Feb 2004	106
4	Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study Brian P. Vickery et al. · The Journal of Allergy and Clinical Immunology In Practice Open access	24 Dec 2020	93
5	An Approach to the Office-Based Practice of Food Oral Immunotherapy Richard L. Wasserman, Jeffrey M. Factor, Hugh H. Windom et al. · The Journal of Allergy and Clinical Immunology In Practice	7 Mar 2021	83
6	SUCCESSFUL ORAL DESENSITIZATION FOR SYSTEMIC PEANUT ALLERGY Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	Aug 2006	54
7	Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma Jonathan Corren, Lyndon E. Mansfield, Tetyana Pertseva et al. · Respiratory Medicine Open access	25 Dec 2012	52
8	Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis Frank C. Hampel, Paul H. Ratner, Lyndon E. Mansfield et al. · Annals of Allergy Asthma & Immunology	Oct 2003	47
9	Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype Stanley James Szefler, Christian Vogelberg, Jonathan A. Bernstein et al. · The Journal of Allergy and Clinical Immunology In Practice Open access	25 Mar 2019	39
10	Office-based oral immunotherapy for food allergy is safe and effective Richard L. Wasserman, Robert W. Sugerman, N. Mireku-Akomeah et al. · Journal of Allergy and Clinical Immunology	31 Oct 2010	26
11	A Comparison of Various Respiratory System Models Based on Parameter Estimates From Impulse Oscillometry Data Tai-Kuo Woo, Bill M. Diong, Lyndon E. Mansfield et al. Conference paper	12 Apr 2005	23
12	Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate Lyndon E. Mansfield, Catherine R. Posey · Allergy and Asthma Proceedings	Mar 2007	20
13	A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma Lyndon E. Mansfield, Gloria Yiu, Anat Sakov et al. · Allergy and Asthma Proceedings	25 May 2017	15
14	The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma Lyndon E. Mansfield · Allergy and Asthma Proceedings	Mar 2008	11
15	Efficacy of Reslizumab in Older Patients (≥65 years) with Asthma and Elevated Blood Eosinophils: Results from a Pooled Analysis of Two Phase 3, Placebo-Controlled Trials David I. Bernstein, Lyndon E. Mansfield, James Zangrilli et al. · Journal of Allergy and Clinical Immunology Open access	Feb 2016	10
16	The reading, writing, and arithmetic of the medical literature, part 2: critical evaluation of statistical reporting Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	Oct 2005	7
17	Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials Lyndon E. Mansfield, Sy Duong‐Quy, Timothy Craig · Advances in Therapy ReviewOpen access	21 Aug 2019	5
18	A Multiallergen and Miniscreen can Change Primary Care Provider Diagnosis and Treatment of Rhinitis Lyndon E. Mansfield, Henry R. Hutteman, Samuel Tyson et al. · American Journal of Rhinology and Allergy	May 2012	5
19	A Valved Holding Chamber Does Not Decrease the Bronchodilator Activity of Budesonide–Formoterol Combination Metered Dose Inhaler Lyndon E. Mansfield, Ruby Maynes · Journal of Asthma	26 Nov 2012	5
20	The reading, writing, and arithmetic of the medical literature, part 3: critical appraisal of primary research Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	2006	5
21	Beclomethasone HFA for the treatment of allergic rhinitis Lyndon E. Mansfield · Expert Opinion on Pharmacotherapy	11 Dec 2015	3
22	Efficacy and Safety of AMG 317, an IL-4Ra Antagonist, in Atopic Asthmatic Subjects: A Randomized, Double-blind, Placebo-controlled Study J. Corren, William W. Busse, Eli O. Meltzer et al. · Journal of Allergy and Clinical Immunology	Mar 2009	3
23	Disorders of the Respiratory Tract: Common Challenges in Primary Care Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	Oct 2006	3
24	Tolerance to cobalt after immunotherapy for cobalt hypersensitivity Lyndon E. Mansfield, Luis Alberto Urrea, Henry R. Hutteman · Annals of Allergy Asthma & Immunology	16 Mar 2012	2
25	Specific Oral Tolerance Induction to Cobalt Lyndon E. Mansfield, Laura Urrea, R HUTTEMAN et al. · Journal of Allergy and Clinical Immunology Open access	Feb 2008	2
26	Device mechanics and evaluation of inspiratory flow rate required of the beclomethasone dipropionate breath-actuated inhaler Lyndon E. Mansfield, Frank C. Hampel, Bernard Sfeir et al. · Allergy and Asthma Proceedings	25 Apr 2019	1
27	Allergy and the bone: connections Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	29 Aug 2011	1
28	The reading, writing, and arithmetic of the medical literature, part 1 Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	Aug 2005	1
29	Web alert Lyndon E. Mansfield · Current Allergy and Asthma Reports	Jul 2008	0
30	Use of a Valved Holding Chamber Does Not Adversely Affect Bronchodilation from Budesonide/Formoterol Pressurized Meter Dose Inhaler (PMDI) Lyndon E. Mansfield, E. Cueto, Ruby Maynes et al. · Journal of Allergy and Clinical Immunology	Feb 2010	0
31	Neuropsychiatric disorders during intranasal corticosteroid therapy Lyndon E. Mansfield · Annals of Allergy Asthma & Immunology	Sep 2008	0
32	Efficacy of Twice Daily Fluticasone Propionate and Formoterol Fumarate Combination Administered Using an HFA pMDI in Patients with Moderate to Severe Asthma Jonathan Corren, Lyndon E. Mansfield, Kirsten Kaiser et al. · Journal of Allergy and Clinical Immunology Open access	Feb 2009	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.